Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: A randomized controlled clinical trial
Author:
- 1 January 2006
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (8) , 1265-1269
Abstract
AIM: To study the therapeutic effect of interferon (IFN) and ribavirin with zinc supplement on patients with chronic hepatitis C viral (HCV) infection.Keywords
This publication has 21 references indexed in Scilit:
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- Zinc supplementation and stunted infants in Ethiopia: a randomised controlled trialThe Lancet, 2000
- Preliminary Study of Combination Therapy with Interferon-α and Zinc in Chronic Hepatitis C Patients with Genotype 1bBiological Trace Element Research, 2000
- Hepatitis CThe Lancet, 1998
- The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-α to hepatitis C patientsBiological Trace Element Research, 1997
- Trace Elements and Chronic Liver DiseasesJournal of Trace Elements in Medicine and Biology, 1997
- Classification of chronic viral hepatitis: a need for reassessmentJournal of Hepatology, 1991
- Effects of zincl-carnosine on gastric mucosal and cell damage caused by ethanol in ratsDigestive Diseases and Sciences, 1990
- Severe Zinc Deficiency1989